Angina Pectoris News and Research

RSS

Skipping nightly toothbrushing could heighten cardiovascular disease risk

Research investigated the impact of toothbrushing timing on cardiovascular disease risk. The study found that brushing teeth at night was associated with lower cardiovascular disease risk compared to not brushing at all.

2 Jul 2023

Heart attack patients with strong legs less likely to develop heart failure

People with strong legs are less likely to develop heart failure after a heart attack, according to research presented today at Heart Failure 2023, a scientific congress of the European Society of Cardiology.

22 May 2023

Heart risks associated with artificial sweeteners

In a recent study published in the British Medical Journal, researchers investigated the relationship between the intake of artificial sweeteners and the risk of all cardiovascular diseases (CVDs), including cardiometabolic disorders.

11 Sep 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Researchers describe failures of the French healthcare system as reflected by increased hospitalizations due to certain acute cardiovascular diseases in 2021.

7 Aug 2022

Long-established drug for angina pectoris shows anti-inflammatory effect, reduces atherosclerotic plaques

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke.

14 Jul 2022

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Scientists have provided a detailed overview on the long-term symptoms experienced by COVID-19 patients after initial primary infection with SARS-CoV-2.

30 Jun 2022

Some COX inhibitors/NSAIDs increase COVID-19 severity

A startling new preprint research paper posted to the medRxiv server warns against the use of commonly used non-steroidal anti-inflammatory drugs (NSAIDs) belonging to the category of cyclooxygenase inhibitors (COX inhibitors) in patients with coronavirus disease 2019 (COVID-19).

22 Apr 2021

The impact of COVID-19 on emergency medical services: a case study

A team of researchers based in Turkey has now studied the pandemic's effect on emergency medical services (EMS). Their study, titled "Effects of COVID‐19 pandemic on emergency medical services," was published in the latest issue of The International Journal of Clinical Practice.

9 Dec 2020

Stress-induced activity in the brain region may predict chest pain in people with coronary artery disease

Stress-induced activity in the inferior frontal lobe of the brain may have a direct correlation with chest pain among people with coronary artery disease.

10 Aug 2020

Study provides evidence on non-invasive diagnostic procedures for people with suspected CHD

The German Institute for Quality and Efficiency in Health Care (IQWiG) used an evidence map to investigate to what extent informative evidence exists on the benefit and harm of the diagnostic procedures "non-invasive computed tomography angiography" (CTA) and "stress MRI" in people with suspected coronary heart disease (CHD).

9 Jul 2020

GlobalData: Diagnosed prevalent cases of angina pectoris expected to reach 22.79 million in 2028

The diagnosed prevalent cases of angina pectoris is expected to increase from 19.58 million cases in 2018 to 22.79 million cases in 2028, at an annual growth rate (AGR) of 1.64% across the seven major markets 7MM, according to GlobalData, a leading data and analytics company.

20 May 2020

Improved optical imaging technique can help identify patients at risk of future heart attacks

Doctors need better ways to detect and monitor heart disease, the leading cause of death in industrialized countries. A team led by Massachusetts General Hospital researchers with support from the National Institute of Biomedical Imaging and Bioengineering has developed an improved optical imaging technique that found differences between potentially life-threatening coronary plaques and those posing less imminent danger for patients with coronary artery disease.

25 Nov 2019

Pesticide exposure on the job related to more strokes, heart attacks

A new study published in the Journal of the American Heart Association, September 25, 2019, reports that the risk of cardiovascular disease (CVD) is increased by 42% in Japanese-American men exposed to high levels of pesticide. This is the first time this outcome has been explored in this group, and indicates that the role played by occupational pesticide exposure in the pathogenesis of CVD needs to be examined.

25 Sep 2019

World Heart Federation launches new roadmap to reduce global burden of CVD in people with diabetes

At ESC Congress 2019 together with the World Congress of Cardiology, the World Heart Federation launched a new “roadmap” aimed at reducing the global burden of CVD in people living with diabetes.

3 Sep 2019

Combination therapy reduces risk of cardiovascular events in heart patients

Patients with a history of coronary heart disease or acute coronary syndrome benefit more from treatment with a statin in combination with ezetimibe than from treatment with a statin alone.

8 Aug 2019

How a simple MRI scan can help patients with angina

Using a simple Magnetic Resonance Imaging (MRI) scan can help doctors diagnose their patients with angina, sparing them from the invasive procedure and an overnight stay in the hospital, a new study suggests.

25 Jun 2019

Poor cardiorespiratory fitness could increase risk of future heart attack, finds new study

Poor cardiorespiratory fitness could increase your risk of a future heart attack, even if you have no symptoms of a lifestyle illness today, a new study has found.

16 Jan 2019

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

Exercise may reduce potential effectiveness of heart drug

Peter Ruben and his team of researchers have spent years studying why seemingly healthy patients with inherited cardiac arrhythmias can sometimes suddenly die during exercise.

8 Mar 2018